195 related articles for article (PubMed ID: 18424035)
1. Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy.
Hayashi S; Yamaguchi Y
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):201-6. PubMed ID: 18424035
[TBL] [Abstract][Full Text] [Related]
2. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
3. Estrogen signaling and prediction of endocrine therapy.
Hayashi S; Yamaguchi Y
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():27-31. PubMed ID: 16273356
[TBL] [Abstract][Full Text] [Related]
4. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Matsumoto M; Yamaguchi Y; Seino Y; Hatakeyama A; Takei H; Niikura H; Ito K; Suzuki T; Sasano H; Yaegashi N; Hayashi S
Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998
[TBL] [Abstract][Full Text] [Related]
5. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
6. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and growth factor signaling pathway: basic approaches for clinical application.
Hayashi S; Sakamoto T; Inoue A; Yoshida N; Omoto Y; Yamaguchi Y
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):433-42. PubMed ID: 14623541
[TBL] [Abstract][Full Text] [Related]
8. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
10. Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.
Mukhopadhyay KD; Liu Z; Bandyopadhyay A; Kirma NB; Tekmal RR; Wang S; Sun LZ
PLoS One; 2015; 10(4):e0121136. PubMed ID: 25837259
[TBL] [Abstract][Full Text] [Related]
11. Basic research for hormone-sensitivity of breast cancer.
Hayashi S; Yamaguchi Y
Breast Cancer; 2006; 13(2):123-8. PubMed ID: 16755105
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells.
Inoue A; Omoto Y; Yamaguchi Y; Kiyama R; Hayashi SI
J Mol Endocrinol; 2004 Jun; 32(3):649-61. PubMed ID: 15171706
[TBL] [Abstract][Full Text] [Related]
13. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
14. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
15. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
16. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
17. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
[TBL] [Abstract][Full Text] [Related]
18. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.
Di GH; Lu JS; Song CG; Li HC; Shen ZZ; Shao ZM
J Exp Clin Cancer Res; 2005 Dec; 24(4):601-7. PubMed ID: 16471323
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
